The independent source for health policy research, polling, and news.
15,981-16,000 of 112,929 results
Since the federal government doesn't maintain a national database of vaccinations, people face confusing methods of record keeping. The upshot: It's on you. Meanwhile, tech companies work on digital health passes--not passports, mind you--for vaccine verification.
Clinical trial data also says that Moderna's vaccine is 95% effective at stopping severe disease for half a year after full vaccination. The company highlights its vaccine has no links to blood clots. Meanwhile, Pfizer is upping production of its version.
The Biden administration is pressured to space out two-dose covid vaccines and address local surges, even as rollout efforts have to be adjusted for the J&J vaccine pause--an issue which will last "days to weeks" but not "weeks to months" according to Dr. Anthony Fauci.
For people who recently got the Johnson & Johnson shot, news outlets report on the extremely rare symptoms to look out for, as well as the science behind blood clots. Longer-term, the suspension could have a huge impact on vaccination fears.
State after state has announced it's following FDA guidelines to pause Johnson & Johnson covid vaccinations, leading to cancelled appointments and a rush to reorganize efforts around alternative vaccines.
Today's early morning highlights from the major news organizations.
Editorial pages tackle these public health topics.
Opinion writers address these Covid and vaccine issues.
India's covid surge may threaten global supplies of vaccines, and the nation also banned exports of the treatment drug remdesivir. Meanwhile, the United Kingdom is entering a broad unlocking phase after meeting its target for vaccinating the over-50s.
The new measure in Hawaii is a response to doctor shortages on some of the state's smaller islands. Other news is from New Mexico, North Carolina, Georgia, Florida and Maryland.
Microsoft buys a speech recognition and artificial intelligence company that could help it make medical record keeping easier. Amazon does more hiring of medical experts.
News from across the country on how people are dealing with covid vaccines and covid restrictions including reports from New Hampshire, Florida, Louisiana, Utah, California and Texas.
The expansion should give 2,500 women with incomes up to 208 percent of the federal poverty level Medicaid coverage for up to a year after giving birth.
The drug industry's lobbying group is also tweaking some of its policy stances including several unprecedented endorsements for drug pricing reforms. But those changes don't go as far as what has been proposed in Congress.
The agency also announced the appointment of Patrizia Cavazzoni as the director of its Center for Drug Evaluation and Research. Cavazzoni has been a senior executive at Pfizer.
Axios reports on the "huge array" of health policies Democrat lawmakers are considering, as the L.A. Times reports on plans to roll back health policies put in place during the Trump administration. In addition, more home care for seniors is in the cards, thanks to $400 million in funding included in the infrastructure plan.
A study of over 20,000 U.S. kids with covid found 12% needed hospital stays, and nearly 1 in 3 of those were "severe" cases needing treatments like ICU care or ventilation. Children are suffering long covid too, and at least five hospitals are starting clinics.
A dramatic increase in covid cases in Michigan caused Biden administration officials to warn that the state should "shut things down" as no corresponding vaccine supply boost will happen -- only more therapeutic drugs.
The British covid variant does not cause more severe disease in hospitalized patients, according to a new study. However, another study says the South African variant may be able to evade the Pfizer vaccine.
More states open vaccine eligibility for adults over 16, bringing the country closer to the point in which almost anyone can sign up for the vaccine. Reports single out New Mexico and Alaska's Native American health providers as being particularly effective at delivering vaccines.
© 2026 KFF